Frontiers | Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials User WalkingHorse, in the LungCancerSupport subreddit, 22 Apr 2024